AlzChem Group AG
ALZCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $575,879 | $254,299 | $261,634 | $246,638 |
| - Cash | $61,544 | $11,883 | $9,243 | $8,285 |
| + Debt | $52,823 | $62,488 | $100,235 | $55,641 |
| Enterprise Value | $567,158 | $304,904 | $352,626 | $293,994 |
| Revenue | $554,231 | $540,649 | $542,223 | $422,293 |
| % Growth | 2.5% | -0.3% | 28.4% | – |
| Gross Profit | $360,725 | $298,932 | $282,724 | $268,338 |
| % Margin | 65.1% | 55.3% | 52.1% | 63.5% |
| EBITDA | $107,493 | $81,752 | $69,857 | $62,684 |
| % Margin | 19.4% | 15.1% | 12.9% | 14.8% |
| Net Income | $54,075 | $34,621 | $30,052 | $27,593 |
| % Margin | 9.8% | 6.4% | 5.5% | 6.5% |
| EPS Diluted | 5.31 | 3.4 | 2.97 | 2.72 |
| % Growth | 56.2% | 14.5% | 9.2% | – |
| Operating Cash Flow | $105,147 | $72,671 | -$4,240 | $43,016 |
| Capital Expenditures | -$43,101 | -$20,557 | -$29,068 | -$28,535 |
| Free Cash Flow | $105,147 | $52,114 | -$33,308 | $14,481 |